fulvestrant has been researched along with am 630 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellini, G; de Novellis, V; Guida, F; Luongo, L; Maione, S; Mancusi, S; Manzo, I; Nobili, B; Rossi, F; Torella, M; Tortora, C | 1 |
1 other study(ies) available for fulvestrant and am 630
| Article | Year |
|---|---|
The 17-β-oestradiol inhibits osteoclast activity by increasing the cannabinoid CB2 receptor expression.
Topics: Acid Phosphatase; Adult; Aged; Aged, 80 and over; Cells, Cultured; Estradiol; Estrogen Antagonists; Estrogens; Female; Fulvestrant; Humans; Indoles; Isoenzymes; Middle Aged; Osteoclasts; Postmenopause; Premenopause; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Response Elements; Tartrate-Resistant Acid Phosphatase; TRPV Cation Channels; Young Adult | 2013 |